Government announces clampdown on fraud in community pharmacy

What could fraud in community pharmacy look like?
The NHSCFA Strategic Intelligence Assessment 2022 report said that pharmaceutical contractor fraud involves the falsification or exaggeration of services, as well as collusion.
Related Article: Updated NHS App to help patients manage prescriptions
During the Covid-19 pandemic, when temporary suspensions were introduced for patient signatures on prescriptions and for the consent required from patients for electronic repeat dispensing, 'it is likely that some pharmacists exaggerated their activities to receive higher monthly payments, including claims for the uncollected prescriptions of university students or over prescribing in bulk for care homes,' the report said.
It also said that Covid-19 provided an opportunity to allow some pharmacists to claim for ‘ghost patients’ within the vaccination programme and to intentionally split transactions when supplying NHS Lateral Flow Device home testing kits.
Additionally, during the height of the pandemic, 'it is likely that a number of pharmacists could have used volunteers to deliver prescriptions to shielding patients or falsified deliveries entirely, but still claimed reimbursement for an outsourced delivery,' the report claimed.
Related Article: Pharmacy First proves popular with public but supply issues cause concern
Meanwhile, 'the intelligence suggests a small minority of pharmacists may have offset revenue shortfalls by claiming reimbursement for Covid-19 related upgrades which were not undertaken,' the report said. 'Reports suggest that some pharmacists could have delayed the submission of claims for drugs dispensed to receive a higher reimbursement, enabled by the monthly price fluctuation being advertised in advance.'
Finally, the report said that 'there is a realistic probability that pharmacists and manufacturers will potentially collude to mutually increase profits. Reports suggest that some manufacturers could have charged an excessive amount for a pharmaceutical special item and then split the profit. Others are believed to have made "kickback" payments to pharmacists in exchange for ordering products from them above alternative manufacturers.'
Related Article: Community pharmacies can provide HPV vaccination from 2026
In 2019, the co-director of a family pharmacy chain in south Wales was sentenced to over a year’s jail time for overcharging the NHS by over £76,000 for medicines, after submitting fraudulent claims for over 1,500 prescriptions.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.